TYP 10.5% 2.1¢ tryptamine therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-21

  1. 1,988 Posts.
    lightbulb Created with Sketch. 1169
    There’s no registered IP around LOAD and EVPS that the Co has ever disclosed.

    If memory serves those technologies are licenced - I read the patents some time ago - I thought they looked to be good tech from memory. Based on solid research by good research groups. I suppose they'd go back to their owners in the event of licence terms not being met (if that happens) and the owners could re-licence them.

    Combining related IP into a more general solution was in my opinion a good idea. But perhaps the company has been ahead of its time, tried to expand to quickly on too much sizzle and insufficient sausage and then COVID hit it hard when it was lacking a bit of focus and overstretched I am not barracking for Ex1 not to work I don't want to write be perceived as writing its obit yet.

    The need for cash though seems like a very substantial challenge. I think it would be pretty impressive if Ian Dixon can get this going again from here.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $22.87M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $27.87K 1.464M

Buyers (Bids)

No. Vol. Price($)
2 527780 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 613000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.